JYNT - NASDAQ

The Joint Corp.

The Joint Corp.

JYNT·NASDAQ

$8.27

-0.54%
HealthcareMedical - Care Facilities

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$117.89M
EPS0.1900
P/E Ratio43.53
Earnings Date08/06/2026

jynt

Other Current Liabilities

Last Annual Value

28.51M

3-Year CAGR

173%

5-Year CAGR

97%

10-Year CAGR

23%

The Joint Corp.

The Joint Corp. Competitors Analysis of Other Current Liabilities

JYNT · NASDAQ
CompanyOther Current Liabilities
CAGR 3Y
CAGR 5Y
CAGR 10Y
JYNT logo
The Joint Corp.
NASDAQ:JYNT
28.51M
1.4%98.5%46.0% 
BTMD logo
biote Corp.
NASDAQ:BTMD
28.31M
67.1%66.5%N/A
IKT logo
Inhibikase Therapeutics, Inc.
NASDAQ:IKT
7.14M
124.0%N/AN/A
CCLD logo
CareCloud, Inc.
NASDAQ:CCLD
11.02M
47.3%-3.3%15.5%
DCGO logo
DocGo Inc.
NASDAQ:DCGO
23.91M
-15.6%15.0%N/A
HURA logo
TuHURA Biosciences, Inc.
NASDAQ:HURA
5.72M
246.9%65.8%67.4%
MBOT logo
Microbot Medical Inc.
NASDAQ:MBOT
2.61M
48.1%N/AN/A
AGEN logo
Agenus Inc.
NASDAQ:AGEN
83.11M
-16.2%1.9%29.3%
ANIK logo
Anika Therapeutics, Inc.
NASDAQ:ANIK
15.87M
-5.4%2.8%16.6%
CLYM logo
Climb Bio, Inc.
NASDAQ:CLYM
2.57M
165.0%N/AN/A
CGTX logo
Cognition Therapeutics, Inc.
NASDAQ:CGTX
11.99M
117.5%37.1%N/A
The Joint Corp.

The Joint Corp. Fair Value Envelope

JYNT · NASDAQ

Our analysis suggests that JYNT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $8.27, this represents a potential HIDDEN relative to our calculated worth for The Joint Corp..

HIDDEN
Intrinsic Value
Current Price: $8.27

Related Guides

Blog Categories

Continue your JYNT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.